1 Min Read
May 15 (Reuters) - Therapeutic Solutions International Inc :
* THERAPEUTIC SOLUTIONS INTERNATIONAL, INC., TO INITIATE CLINICAL TRIAL OF PATENTED CANCER IMMUNOTHERAPY ADJUVANT NANOSTILBENE Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.